Gene · 5698
Papers4,120
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 4,120
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Evidence for Maternal Autoantibodies in the Pathogenesis of Preterm Birth. | medRxiv | 2025 | 41568202 | PubTator, text mining | PubMed |
| Identification of novel therapeutic targets for diabetic neuropathy through integrated proteomics and transcriptomics approaches. | World J Diabetes | 2025 | 41480606 | PubTator, text mining | PubMed |
| Next-generation cell lines for profiling different proteasome forms and their implications in cancer. | Front Immunol | 2025 | 41476979 | PubTator, text mining | PubMed |
| Zinc-Related Proteasome Variants in Type 1 Diabetes: An in Silico-Guided Case-Control Study. | Metabolites | 2025 | 41441015 | PubTator, text mining | PubMed |
| Novel ubiquitination-related biomarkers for Crohn's disease identified by multi-omics study and experimental validation. | Front Immunol | 2025 | 41425573 | PubTator, text mining | PubMed |
| Single-Cell Transcriptome-Wide Mendelian Randomization and Colocalization Analyses Uncover Cell-Specific Mechanisms in Epigenetic Age Acceleration. | FASEB J | 2025 | 41378907 | PubTator, text mining | PubMed |
| Proteasome inhibition as a potential therapeutic target in thymic cancer. | Cell Death Dis | 2025 | 41339338 | PubTator, text mining | PubMed |
| Vemurafenib Activates PSMB9 to Induce Ferroptosis via Free Iron Accumulation and Inhibits Melanoma Progression. | J Biochem Mol Toxicol | 2025 | 41183120 | PubTator, text mining | PubMed |
| Immunoproteasome components LMP2, PSME1, and PSME2 as novel tissue biomarkers predicting response and survival in neoadjuvant chemoimmunotherapy for resectable NSCLC. | Front Immunol | 2025 | 41035633 | PubTator, text mining | PubMed |
| PSMB9 Orchestrates Tumor Immune Landscape and Serves as a Potent Biomarker for Prognosis and T Cell-Based Immunotherapy Response. | Curr Issues Mol Biol | 2025 | 41020834 | PubTator, text mining | PubMed |
| Engineering Universal Cancer Immunity: Non-Tumor-Specific mRNA Vaccines Trigger Epitope Spreading in Cold Tumors. | Vaccines (Basel) | 2025 | 41012173 | PubTator, text mining | PubMed |
| Immunotherapy of Oncovirus-Induced Cancers: A Review on the Development and Efficacy of Targeted Vaccines. | Vaccines (Basel) | 2025 | 41012117 | PubTator, text mining | PubMed |
| Immunoproteasome remodeling in senescing human macrophages reveals the loss of PA28αβ capping as a hallmark of immunosenescence. | Commun Biol | 2025 | 41006761 | PubTator, text mining | PubMed |
| Novel Therapeutic Development for Nasopharyngeal Carcinoma. | Curr Oncol | 2025 | 41002550 | PubTator, text mining | PubMed |
| Proteasome-mediated ubiquitination in neural regeneration. | Biomed Pharmacother | 2025 | 40991984 | PubTator, text mining | PubMed |
| Advances in Adoptive Cell Therapies in Cancer: From Mechanistic Breakthroughs to Clinical Frontiers and Overcoming Barriers. | Med Sci (Basel) | 2025 | 40981188 | PubTator, text mining | PubMed |
| Classification of Paediatric Celiac Disease Using RNA Sequencing and Real-Time PCR of Duodenal Biomarkers. | J Cell Mol Med | 2025 | 40977520 | PubTator, text mining | PubMed |
| Epstein-Barr Virus in Multiple Sclerosis: Past, Present, and Future. | Neurol Neuroimmunol Neuroinflamm | 2025 | 40953326 | PubTator, text mining | PubMed |
| Biased and Inflexible Interpretations of Social Situations Predict Affect Intensity and Variability in Children and Adolescents. | Res Child Adolesc Psychopathol | 2025 | 40906292 | PubTator, text mining | PubMed |
| Dose-dependent interferon programs in myeloid cells after mRNA and adenovirus COVID-19 vaccination. | bioRxiv | 2025 | 40894688 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5698/papers?page=4